mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.053 |
0.6 |
mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.6 |
mRNA |
Bosutinib |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.6 |
mRNA |
GSK2636771 |
CTRPv2 |
pan-cancer |
AAC |
0.021 |
0.6 |
mRNA |
brivanib |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.6 |
mRNA |
ML210 |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.6 |
mRNA |
BRD-K11533227 |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
BRD-K84807411 |
CTRPv2 |
pan-cancer |
AAC |
0.035 |
0.6 |
mRNA |
COL-3 |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.6 |
mRNA |
Axitinib |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.6 |